Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Cintas Analysts Increase Their Forecasts After Upbeat Earnings

Published 28/03/2024, 16:28
Updated 28/03/2024, 17:40
© Reuters. Cintas Analysts Increase Their Forecasts After Upbeat Earnings

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Cintas Corporation (NASDAQ: CTAS) reported better-than-expected third-quarter financial results and raised FY24 guidance.

Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company’s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from Benzinga Pro.

Todd M. Schneider, Cintas’ President, and Chief Executive Officer, stated, “Each of our operating segments continue to execute at a high level, which led to robust revenue growth of 9.9%, record high gross margin of 49.4%, record high operating margin of 21.6% and diluted EPS growth of 22.3%.”

Cintas increased FY24 annual revenue expectations from $9.48 billion-$9.56 billion to $9.57 billion-$9.60 billion (estimate: $9.56 billion). The firm raised EPS outlook from $14.35-$14.65 to $14.80-$15.00 (estimate: $14.60).

Cintas shares rose 0.1% to trade at $686.63 on Thursday.

These analysts made changes to their price targets on Cintas following earnings announcement.

  • Baird raised the price target on Cintas from $660 to $750. Baird analyst Andrew Wittmann maintained an Outperform rating.
  • B of A Securities increased the price target on Cintas from $700 to $790. B of A Securities analyst Heather Balsky maintained a Buy rating.
  • UBS boosted the price target on Cintas from $680 to $790. UBS analyst Joshua Chan maintained a Buy rating.
  • Truist Securities raised the price target on Cintas from $660 to $775. Truist Securities analyst Jasper Bibb maintained a Buy rating.
  • RBC Capital boosted the price target on Cintas from $675 to $725. RBC Capital analyst Ashish Sabadra maintained an Outperform rating.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'

Latest Ratings for CTAS

Jan 2022Morgan StanleyMaintainsEqual-Weight
Dec 2021Argus ResearchMaintainsBuy
Dec 2021Morgan StanleyMaintainsEqual-Weight

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.